✦ LIBER ✦

Development of a solvate as an active pharmaceutical ingredient: Developability, crystallisation and isolation challenges

✍ Scribed by Julien Douillet; Neil Stevenson; Mei Lee; Franck Mallet; Richard Ward; Peter Aspin; Daniel Robert Dennehy; Laure Camus

Book ID: 116629947
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 764 KB
Volume: 342
Category: Article
ISSN: 0022-0248
DOI: 10.1016/j.jcrysgro.2011.05.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and Characterization of a Co

Development and Characterization of a Cocrystal as a Viable Solid Form for an Active Pharmaceutical Ingredient

✍ Kim, Soojin; Li, Zhibin; Tseng, Yin-Chao; Nar, Herbert; Spinelli, Earl; Varsolon 📂 Article 📅 2013 🏛 American Chemical Society 🌐 English ⚖ 520 KB

Crystallization Process Development of a

Crystallization Process Development of an Active Pharmaceutical Ingredient and Particle Engineering via the Use of Ultrasonics and Temperature Cycling

✍ Kim, Soojin; Wei, Chenkou; Kiang, San 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 314 KB

HPTLC methods to assay active ingredient

HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps

✍ D.H. Shewiyo; E. Kaale; P.G. Risha; B. Dejaegher; J. Smeyers-Verbeke; Y. Vander 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 793 KB

Development of an Ingredient Containing

Development of an Ingredient Containing Apple Peel, as a Source of Polyphenols and Dietary Fiber

✍ Carolina Henríquez; Hernán Speisky; Italo Chiffelle; Tania Valenzuela; Manuel Ar 📂 Article 📅 2010 🏛 Institute of Food Technologists 🌐 English ⚖ 432 KB

Development of a stability-indicating UP

Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms

✍ Ch. Krishnaiah; M. Vishnu Murthy; Ramesh Kumar; K. Mukkanti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 702 KB

DEVELOPMENT OF A STABILITY-INDICATING UP

DEVELOPMENT OF A STABILITY-INDICATING UPLC METHOD FOR DETERMINING ZIPRASIDONE HYDROCHLORIDE AND ITS ASSOCIATED DEGRADATION PRODUCTS PRESENT IN ACTIVE PHARMACEUTICAL INGREDIENTS AND PHARMACEUTICAL DOSAGE FORMS

✍ Raj, Shiva ;Kumari, K. Siva ;Krishnaiah, Ch. ;Rao, A. Narasimha 📂 Article 📅 2013 🏛 Taylor and Francis Group 🌐 English ⚖ 532 KB